CSF plasmablasts differentiate MS from other neurologic disorders.
暂无分享,去创建一个
[1] H. Wiendl,et al. Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis , 2020, Journal of Neuroimmunology.
[2] V. Fleischer,et al. Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression , 2016, Multiple sclerosis.
[3] A. Petzold. Intrathecal oligoclonal IgG synthesis in multiple sclerosis , 2013, Journal of Neuroimmunology.
[4] J. Gratama,et al. Flow cytometric characterization of cerebrospinal fluid cells , 2011, Cytometry. Part B, Clinical cytometry.
[5] A. Lutterotti,et al. Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis , 2008, PloS one.
[6] F. Barkhof,et al. Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria , 2005, Annals of neurology.
[7] H. Hartung,et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis , 2005 .
[8] B. Hemmer,et al. Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases , 2013, Journal of Neurology.